Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Boris Bogdan, M.D

Advertisement

Articles by Boris Bogdan, M.D

New Product Launch Playbook: Shaking up Status Quo in Pharma Marketing

ByBoris Bogdan, M.D
May 25th 2018

Pharmaceutical Executive

In this demanding environment, yesterday’s product launch playbook can no longer be relied upon to yield the expected patient or business outcomes, writes Boris Bogdan.

Advertisement

Latest Updated Articles

  • New Product Launch Playbook: Shaking up Status Quo in Pharma Marketing
    New Product Launch Playbook: Shaking up Status Quo in Pharma Marketing

    May 25th 2018



Advertisement
Advertisement

Trending on PharmExec

1

Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors

2

Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report

3

BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies

4

The Science of Targeting Multiple Immune Components in ITP: Q&A with Dr. Srikanth Nagalla

5

What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us